JTAP TECHNOLOGIES, LLC — Department of Defense SBIR Phase I: DHA17-010
JTAP TECHNOLOGIES, LLC — SBIR Phase I award from Department of Defense.
- Amount
- $150,000
- Agency
- Department of Defense · Defense Health Program
- Program / Phase
- SBIR · Phase I
- Topic
- DHA17-010
- Solicitation
- 2017.1
- NAICS
- —
- Place of performance
- VA
- Period
- 2017-09-25 → 2018-04-28
Description
The goal of this project is to develop an operational medical device to target and mitigate intracranial hemorrhage in advance of surgical intervention. This will require the development of a prototype device that targets specific volumes of tissues. The technology could be coupled with existing or novel imaging/targeting methods. The device will be designed to treat epidural hematoma (EDH) and also demonstrated for superficial subarachnoid hemorrhage. The phase II goal of this project is to conduct FDA-suitable in vivo preclinical trials with the prototype device in preparation for human clinical trials. Although the stated objective is to treat EDH, subdural hematoma and hemorrhagic stroke treatments are logical extensions of the technology. The technologies developed in the execution of this project hold the potential to treat unrelated conditions such as invasive tumor growth or to activate drugs in specific tissues.